Article Topic
June 25, 2024: WHO alert about counterfeit Ozempic; a warning about fake Mounjaro and Zepbound
Fake Ozempic has been found in Brazil, the U.K., and the U.S. Eli Lilly warned the public about fake and compounded tirzepatide medicines. Additional domestic and international stories.
[...]June 17, 2024: FL continues to spend money on Canadian drug importation that doesn’t import medicine; GLP-1 phishing scams increase
Florida still has not imported a single pill, patients seeking GLP-1 medicines at increased risk from phishing scams, the counterfeit medicine news from three other countries.
[...]Eli Lilly issues new alert about fake and dangerous compounded weight loss injectables
“Lilly Warns Patients About Counterfeit and Compounded Medicines Releases Open Letter and Takes Further Legal Action Against Counterfeit, Fake, Unsafe, and Untested Products”
[...]June 10, 2024: U.S. drug shortages in 2023 and more counterfeit Ozempic seized
The FDA published its annual drug shortage report for 2023, CBP in Cincinnati seized multiple shipments of fake Ozempic, and international counterfeit medicine stories out of six different countries.
[...]PSM Testimony: NY state bill AB 7954 (Wholesale Canadian drug importation)
PSM submitted a letter to leaders in the New York State legislature opposing a legislative proposal (AB 7954) to setup a wholesale Canadian drug importation program. The bill died right before end of session.
[...]PSM alerts public to criminal medicine activity on gay dating apps
PSM and ADAP Advocacy launched a campaign today about the dangers of medicine diversion criminals operating on gay dating apps such as Grindr. Learn more and report the crime on our campaign page.
[...]June 3, 2024: CAST Act introduced in the Senate
The CAST Act introduced in the Senate. More lawsuits against copycat Wegovy sellers. Pill presses seized in multiple countries. Read about these and other stories in our weekly counterfeit medicine news roundup.
[...]PSM Testimony: Colorado Prescription Drug Affordability Board Meeting, June 7, 2024
A Colorado board is considering setting a price limit on the medicine Stelara. This will have unintended consequences, undermining the safety of the supply chain for this medicine and limiting patient access. Learn more by reading our testimony.
[...]Colorado’s Canadian Rx import plan fuels counterfeit Ozempic dangers
Executive Director Shabbir Safdar’s editorial ran on May 15, 2024 in Colorado Politics
[...]How Upper Payment Limits on medicine increase the risk of diverted and counterfeit medicine in the drug supply
States like Colorado are experimenting with Prescription Drug Affordability Boards to address the price of medicine, but solutions like Upper Payment Limits will yield multiple unintended consequences that will do more harm than good to patients.
[...]